Amar Natarajan, PhD
Ruth Branham Professor, UNMC Eppley Institute for Research in Cancer and Allied Diseases
Co-Director, Eppley Structural Biology Facility
Research focus: Developing novel target and mechanism specific therapeutics
Amar Natarajan is the Ruth Branham Professor in the UNMC Eppley Institute for Research in Cancer and Allied Diseases.
He joined the University of Nebraska Medical Center in 2009 as an associate professor and was promoted to full professor in 2014. In 2017 he was appointed as a co-program leader and co-director of the Structural Biology facility of the Fred & Pamela Buffett Cancer Center, and appointed as Ruth Branham Professor in 2021. Dr. Natarajan started his independent career as an assistant professor at the University of Texas Medical Branch, Galveston TX.
Dr. Natarajan also holds courtesy appointments in the UNMC departments of Genetics, Cell Biology and Anatomy, and Pharmaceutical Sciences.
- BS, Madras Christian College, Chennai, India 1994
- MS, Indian Institute of Technology, Chennai, India 1996
- PhD, University of Vermont, Burlington, VT, 2001
- Postdoc, Harvard Medical School, Cambridge, MA, 2005
- Small-molecule IKKβ activation modulator (IKAM) targets MAP3K1 and inhibits pancreatic tumor growth
- Spirocyclic dimer SpiD7 activates the unfolded protein response to selectively inhibit growth and induce apoptosis of cancer cells
- Aminopyrazole based CDK9 PROTAC sensitizes pancreatic cancer cells to venetoclax
-
President, UNMC Faculty Senate 2023-24
- Research Leadership Award UNMC, 2020
- Panel member Drug Discovery and Pharmacology (DMP) study section NIH, 2016–2020
- Eppley Faculty Senator, UNMC, 2013–2025
- Distinguished Scientist UNMC, 2012
- Emerging Inventor Award, UNeMed, 2010
- Graduate Program Teaching Honoree, GSBS, UTMB, 2007
- Translational Young Investigator Award, ECOG, 2006
- Zinsser Analytical Young Investigator Award, SPSCCL, 1999
University of Nebraska Medical Center
986805 Nebraska Medical Center
Omaha, NE 68198-6805